Wilson's disease with hepatic presentation in childhood
Related Experiment Video
Updated: Oct 17, 2026

Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders
Published on: April 28, 2023
1Division of Gastroenterology, Department of Pediatrics, Hacettepe University, Faculty of Medicine, Ankara, Turkiye. haozen@hacettepe.edu.tp
Insights
Wilson's disease in children often presents with liver issues. Early diagnosis and consistent treatment are crucial for managing this genetic disorder and preventing severe outcomes like liver failure.
Area of Science:
- Pediatric Hepatology
- Genetic Metabolic Disorders
- Clinical Medicine
Background:
- Wilson's disease is a rare genetic disorder of copper metabolism.
- Hepatic presentation is common in pediatric Wilson's disease, often leading to significant morbidity.
- Timely diagnosis and management are critical to prevent irreversible liver damage.
Purpose of the Study:
- To analyze the clinical features, diagnostic methods, treatment strategies, and long-term outcomes of pediatric Wilson's disease with a primary hepatic presentation.
- To identify key indicators for early diagnosis and predict prognosis in affected children.
Main Methods:
- A retrospective study was conducted at a university medical center.
- Data from 34 children diagnosed with Wilson's disease (hepatic presentation) over 18 years were analyzed.
- Diagnosis relied on family history, Kayser-Fleischer rings, low serum ceruloplasmin, and elevated copper in urine and liver tissue.
Main Results:
- Common symptoms included abdominal pain and distension; hepatomegaly and elevated transaminases were frequent findings.
- Eight patients presented with fulminant hepatic failure, and 20 had cirrhosis.
- Treatment involved D-penicillamine and zinc sulfate; 3 patients received liver transplants. Long-term follow-up revealed that poor compliance correlated with disease progression.
Conclusions:
- Wilson's disease should be strongly suspected in children with unexplained liver disease, particularly with a positive family history or parental consanguinity.
- Consistent adherence to treatment is vital for long-term stability and preventing decompensated cirrhosis.
Objective:
To evaluate clinical, laboratory findings, treatment and long-term follow-up of children with Wilson's disease with hepatic presentation.
Design:
Retrospective study with a median follow-up period of 9 years.
Setting:
University medical center.
Subjects:
Thirty-four children with hepatic involvement, ranging in age from three to fifteen years, were diagnosed as Wilson's disease over an eighteen year period.
Methods:
The diagnosis was based on the presence of family history and Kayser-Fleischer rings, low serum ceruloplasmin levels and increased urinary and hepatic copper concentrations.
Results:
Four patients had also neurological manifestations. Eight patients were diagnosed as fulminating hepatic failure resulting in death in a few days. The most common symptoms were abdominal distension and abdominal pain. Hepatomegaly was the predominant physical finding and serum transaminases were elevated in most of the patients. Twenty patients had cirrhosis and six had chronic hepatitis histopathologically. All patients with fulminating hepatic failure had hyperbilirubinemia with normal alkaline phosphatase and higher aspartate aminotransferase than alanine aminotransferase. Patients were treated with D-penicillamine and zinc sulphate. Three patients underwent liver transplantation. Four more patients besides patients with fulminating hepatic failure died due to end stage liver disease. Twenty-two patients were followed for median 9 years. Four patients with poor compliance progressed to decompensated cirrhosis and the others were stable.
Conclusions:
Liver disease with unknown origin with positive family history and parental consanguinity should imply Wilson's disease strongly.
Related Concept Videos
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Cirrhosis I: Introduction
Pharmacokinetics in Pediatric Patients: Drug Excretion
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow